GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » Receivables Turnover

MDXXF (Pharmala Biotech Holdings) Receivables Turnover : 0.77 (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Pharmala Biotech Holdings Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Pharmala Biotech Holdings's Revenue for the three months ended in Feb. 2024 was $0.07 Mil. Pharmala Biotech Holdings's average Accounts Receivable for the three months ended in Feb. 2024 was $0.09 Mil. Hence, Pharmala Biotech Holdings's Receivables Turnover for the three months ended in Feb. 2024 was 0.77.

Pharmala Biotech Holdings Receivables Turnover Historical Data

The historical data trend for Pharmala Biotech Holdings's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmala Biotech Holdings Receivables Turnover Chart

Pharmala Biotech Holdings Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Receivables Turnover
- 3.33 6.53 6.06

Pharmala Biotech Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 Aug24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.17 5.69 0.77 -

Competitive Comparison of Pharmala Biotech Holdings's Receivables Turnover

For the Biotechnology subindustry, Pharmala Biotech Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmala Biotech Holdings's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmala Biotech Holdings's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Pharmala Biotech Holdings's Receivables Turnover falls into.


Pharmala Biotech Holdings Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Pharmala Biotech Holdings's Receivables Turnover for the fiscal year that ended in Aug. 2024 is calculated as

Receivables Turnover (A: Aug. 2024 )
=Revenue / Average Total Inventories
=Revenue (A: Aug. 2024 ) / ((Accounts Receivable (A: Aug. 2023 ) + Accounts Receivable (A: Aug. 2024 )) / count )
=0.758 / ((0.103 + 0.147) / 2 )
=0.758 / 0.125
=6.06

Pharmala Biotech Holdings's Receivables Turnover for the quarter that ended in Feb. 2024 is calculated as

Receivables Turnover (Q: Feb. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Feb. 2024 ) / ((Accounts Receivable (Q: Nov. 2023 ) + Accounts Receivable (Q: Feb. 2024 )) / count )
=0.067 / ((0.09 + 0.084) / 2 )
=0.067 / 0.087
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings  (OTCPK:MDXXF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Pharmala Biotech Holdings Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » Receivables Turnover
Comparable Companies
XCNQ:DOSE XCNQ:TELI TSX:APS XCNQ:PHRM TSXV:TTI XCNQ:BIOV TSXV:SBM TSXV:GSD TSXV:CYTO TSXV:RKV VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
MDMA:Canada
Address
82 Richmond Street East, Toranto, ON, CAN, M5C 1P1
Website
https://www.pharmala.ca
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. PharmAla's drug API is manufactured and encapsulated under GMP conditions. The Company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations.